Used as a chiral intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its structure supports the formation of peptide-like chains with enhanced metabolic stability, making it valuable in medicinal chemistry for optimizing drug candidates. The presence of the trifluoromethyl group improves lipophilicity and bioavailability, while the Boc-protected amine allows for selective deprotection and further functionalization in multi-step syntheses. Commonly employed in research settings for designing enzyme inhibitors and central nervous system agents.